13F-HR filed by TCG Crossover Management, LLC
TCG Crossover Management, LLC filed this 13F-HR for the quarter ended 2025-03-31, filed 2025-05-14, with 38 holding rows worth $733,085,569.
- Accession
- 0001214659-25-007553
- Filer
- CIK 1839948
- Filed
- 2025-05-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2025
A holdings report, 38 entries on the cover page, a total value of $733,085,569 stated on the cover page (in dollars after the unit check, H1), rows summing to $733,085,569 with VALUE read as dollars as filed, 13F file number 028-22283. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| CG ONCOLOGY INC | 156944100 | COMMON STOCK | 3,670,206 | $89,883,345 | dollars as filed | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 6,964,375 | $41,716,606 | dollars as filed | |
| CENTESSA PHARMACEUTICALS PLC | 152309100 | SPONSORED ADS | 2,890,816 | $41,569,934 | dollars as filed | |
| MINERALYS THERAPEUTICS INC | 603170101 | COM | 2,470,265 | $39,227,808 | dollars as filed | |
| OCULAR THERAPEUTIX INC | 67576A100 | COM | 5,319,148 | $38,989,355 | dollars as filed | |
| ABIVAX SA- | 00370M103 | SPONSORED ADS | 6,056,596 | $37,853,725 | dollars as filed | |
| SAVARA INC | 805111101 | COM | 12,362,205 | $34,243,308 | dollars as filed | |
| DYNE THERAPEUTICS INC COM | 26818M108 | Stock | 2,650,150 | $27,720,569 | dollars as filed | |
| DIANTHUS THERAPEUTICS INC | 252828108 | COM | 1,501,624 | $27,239,459 | dollars as filed | |
| TYRA BIOSCIENCES INC | 90240B106 | COMMON STOCK | 2,898,103 | $26,952,358 | dollars as filed | |
| XENCOR INC | 98401F105 | COMMON STOCK | 2,452,138 | $26,090,748 | dollars as filed | |
| DISC MEDICINE INC COM | 254604101 | Stock | 465,257 | $23,095,357 | dollars as filed | |
| Tourmaline Bio Inc | 89157D105 | Common Stock | 1,477,593 | $22,474,190 | dollars as filed | |
| CIDARA THERAPEUTICS INC | 171757206 | COM NEW | 1,005,901 | $21,667,108 | dollars as filed | |
| AMYLYX PHARMACEUTICALS INC | 03237H101 | COM | 5,943,812 | $21,041,094 | dollars as filed | |
| SOLENO THERAPEUTICS INC | 834203309 | COM | 275,000 | $19,648,750 | dollars as filed | |
| EYEPOINT INC COM NEW | 30233G209 | Stock | 3,572,335 | $19,362,056 | dollars as filed | |
| STRUCTURE THERAPEUTICS INC COMP | 86366E106 | EQUITY | 1,063,000 | $18,400,530 | dollars as filed | |
| UPSTREAM BIO INC | 91678A107 | COMMON STOCK | 2,801,763 | $17,146,790 | dollars as filed | |
| RAPT THERAPEUTICS INC | 75382E109 | COM | 13,090,200 | $15,970,044 | dollars as filed | |
| FULCRUM THERAPEUTICS INC | 359616109 | COMMON STOCK | 5,250,000 | $15,120,000 | dollars as filed | |
| ASTRIA THERAPEUTICS INC COM | 04635X102 | Stock | 2,761,861 | $14,748,338 | dollars as filed | |
| TANGO THERAPEUTICS INC | 87583X109 | COM | 10,736,000 | $14,708,320 | dollars as filed | |
| COMPASS PATHWAYS PLC | 20451W101 | SPONSORED ADS | 3,858,000 | $11,033,880 | dollars as filed | |
| KURA ONCOLOGY INC COM | 50127T109 | Stock | 1,423,642 | $9,396,037 | dollars as filed | |
| THIRD HARMONIC BIO INC | 88427A107 | COM | 2,505,424 | $8,693,821 | dollars as filed | |
| SILENCE THERAPEUTICS PLC | 82686Q101 | ADS | 3,033,560 | $8,554,639 | dollars as filed | |
| ADVERUM BIOTECHNOLOGIES INC | 00773U207 | COM NEW | 1,796,482 | $7,850,626 | dollars as filed | |
| VISTAGEN THERAPEUTICS INC | 92840H400 | COM | 2,676,580 | $6,691,451 | dollars as filed | |
| AEROVATE THERAPEUTICS INC | 008064107 | COM | 2,240,809 | $5,624,431 | dollars as filed | |
| ENTRADA THERAPEUTICS INC COM | 29384C108 | Stock | 584,955 | $5,287,993 | dollars as filed | |
| MBX BIOSCIENCES INC COM | 55287L101 | Stock | 650,000 | $4,797,000 | dollars as filed | |
| AVALO THERAPEUTICS INC | 05338F306 | COMMON STOCK | 483,000 | $3,868,830 | dollars as filed | |
| KODIAK SCIENCES INC | 50015M109 | COM | 1,145,538 | $3,213,234 | dollars as filed | |
| NEKTAR THERAPEUTICS | 640268108 | COM | 4,000,000 | $2,720,000 | dollars as filed | |
| Ventyx Biosciences Inc | 92332V107 | Common Stock | 316,195 | $363,624 | dollars as filed | |
| CABALETTA BIO INC | 12674W109 | COMMON STOCK | 86,795 | $120,211 | dollars as filed | |
| KEROS THERAPEUTICS INC COM | 492327101 | Stock | 0 | $0 | dollars as filed | Value filed as zero, left out of ratios.Amount filed as zero, left out of ratios. |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001214659-25-007553 | this filing | 2025-05-14 | acceptance time not in the bulk data set |